Statin Intolerance: an Overview of US and International Guidance
Open Access
- 6 July 2023
- journal article
- review article
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 25 (8) , 517-526
Abstract
Purpose of Review: To review recent international and domestic definitions, considerations, and treatment algorithms for statin intolerance, and specifically, statin-associated muscle symptoms (SAMS). Recent Findings: Multiple organizations around the world have produced guidance documents to aid clinicians on managing statin intolerance. A common theme resides among all the guidance documents that most patients can tolerate statins. For those patients who cannot, healthcare teams need to evaluate, rechallenge, educate, and ensure adequate reduction of atherogenic lipoproteins. Summary: Statin therapy remains the cornerstone of lipid-lowering therapies to reduce atherosclerotic cardiovascular disease (ASCVD) and reduce mortality and morbidity. The common theme throughout all these guidance documents is the importance of statin therapy to reduce ASCVD and continual adherence to treatment. Because adverse events occur and inhibit patients from achieving adequate lowering of their atherogenic lipoproteins, trial and rechallenge of statin therapy, as well as addition of non-statin therapies, especially in high-risk patients, is also undisputed. The main differences stem from laboratory monitoring and the classification of the severity of the adverse effect. Future research should focus on consistently diagnosing SAMS so that these patients can be easily identified in the electronic health records.Keywords
This publication has 12 references indexed in Scilit:
- The STatin Adverse Treatment Experience Survey: Experience of patients reporting side effects of statin therapyJournal of Clinical Lipidology, 2019
- Alirocumab and Cardiovascular Outcomes after Acute Coronary SyndromeNew England Journal of Medicine, 2018
- Update on SAMS: Statin-associated muscle symptomsAtherosclerosis, 2018
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular DiseaseNew England Journal of Medicine, 2017
- Statin-associated muscle symptoms: position paper from the Luso-Latin American ConsortiumCurrent Medical Research and Opinion, 2016
- Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016)Canadian Journal of Cardiology, 2016
- Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and ManagementEuropean Heart Journal, 2015
- An assessment by the Statin Intolerance Panel: 2014 updateJournal of Clinical Lipidology, 2014
- Treatment strategies in patients with statin intolerance: The Cleveland Clinic experienceAmerican Heart Journal, 2013
- Discontinuation of Statins in Routine Care SettingsAnnals of Internal Medicine, 2013